RICHARD KUNTZ, M.D., M.SC.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

DiaMedica Therapeutics Inc.

Filing Date Source Excerpt
2024-04-04 "His major interests are traditional and alternative clinical trial design and biostatistics... Dr. Kuntz received his Master of Science in biostatistics"
2025-03-28 "Dr. Kuntz received his Master of Science in biostatistics from the Harvard T.H. Chan School of Public Health."

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09